Z-1476-2025 Class II Ongoing

Recalled by Stryker Corporation — Portage, MI

FDA device recall Z-1476-2025 was initiated by Stryker Corporation on Feb 25, 2025 and is designated Class II. Reason for recall: There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal… The recall status is ongoing. Affected quantity: 182,344 total units.

Recall details

Product Type
Devices
Report Date
Apr 9, 2025
Initiation Date
Feb 25, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
182,344 total units

Product description

Nasopore FD fragmentable nasal dressing, Catalog Numbers 5400-020-108 and 5400-020-108ITL

Reason for recall

There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that the sterility seal has been breached.

Distribution pattern

US Nationwide distribution.

Code information

5400-020-108 UDI-DI: 07613327117226, Lot Numbers: 2023011317 2023021717 2023030932 2023040317 2023083017 2023102517 2024020517 2024080717; 5400-020-108ITL UDI-DI: 07613327117226, Lot Numbers: 2023012017 2023032817 2023042017 2023091117 2023111417 2023120517 2024011817 2023020732 2023041117 2023062017 2023092017 2023112017 2024010817 2024012417 2023031717 2023041417 2023082317 2023103117 2023112817 2024011217

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1476-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1476-2025. Report a data issue: hello@regdatalab.com.